Harbin Gloria Pharmaceuticals Co., Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Harbin Gloria Pharmaceuticals Co., Ltd with three other
companies in this sector in China:
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
sales of 2.86 billion Chinese Renmimbi [US$415.84 million]
of which 54%
was Medicine Manufacturing),
Jiangsu Kanion Pharmaceutical Co., Ltd.
(3.00 billion Chinese Renmimbi [US$435.58 million]
of which 100%
was Exportation Trade), and
Guangdong Taiantang Pharmaceutical Co Ltd
(3.07 billion Chinese Renmimbi [US$446.36 million]
Harbin Gloria Pharmaceuticals Co., Ltd reported sales of 2.98 billion Chinese Renmimbi (US$433.09 million)
December of 2016.
increase of 10.5%
versus 2015, when the company's sales were 2.70 billion Chinese Renmimbi.
Sales at Harbin Gloria Pharmaceuticals Co., Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 446%).
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
197.2% in 2016, from
16.51 million Chinese Renmimbi to 49.06 million Chinese Renmimbi.
Harbin Gloria Pharmaceuticals Co., Ltd also saw significant increases in sales in
Pharmaceutical Agents (up 61.3% to 578.50 million Chinese Renmimbi)
Pharmaceutical Research and Clinical Servi (up 35.3% to 47.50 million Chinese Renmimbi)
Financial Service (up 136.9% to 5.02 million Chinese Renmimbi)